Pfizer and biontech receive expanded u.s. emergency use authorization for an additional covid-19 vaccine booster in individuals aged 50 years and older

New york & mainz, germany--(business wire)--pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced that the u.s. food and drug administration (fda) has expanded the emergency use of their covid-19 vaccine to include a second booster dose in adults ages 50 years and older who have previously received a first booster of any authorized covid-19 vaccine. the fda also has authorized a second booster dose for individuals 12 years of age and older who have been determined to have certa
BNTX Ratings Summary
BNTX Quant Ranking